Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Do we have the date for the AGM ?

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on May 09, 2022 2:51pm

109 Views

Post# 34667986

RE:RE:Do we have the date for the AGM ?

It's tomorrow. You can look at SEC or SEDAR filings to get that info. Anyone in Montreal, here's the address so you can attend if you want to meet Board members and management.

NOTICE IS HEREBY GIVEN that an annual meeting of shareholders (the “Meeting”) of the Corporation will be held at the International Air Transport Association, 800 Square-Victoria, 11th floor, Montreal, Quebec, on Tuesday, May 10, 2022 at 10:00 a.m. (Eastern Time) for the following purposes